DrugPatentWatch Database Preview

Keryx Biopharms Company Profile

« Back to Dashboard

What is the competitive landscape for KERYX BIOPHARMS, and what generic alternatives to KERYX BIOPHARMS drugs are available?

KERYX BIOPHARMS has one approved drug.

There are fourteen US patents protecting KERYX BIOPHARMS drugs.

There are one hundred and sixteen patent family members on KERYX BIOPHARMS drugs in twenty-six countries.

Summary for Keryx Biopharms

International Patents:	116
US Patents:	14
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Keryx Biopharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	5,753,706		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,609,896		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,901,349
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	9,757,416		Y	Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,093,423
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	9,050,316

Expired US Patents for Keryx Biopharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014	5,753,706

International Patents for Keryx Biopharms Drugs

Country	Patent Number	Estimated Expiration
China	100386336
World Intellectual Property Organization (WIPO)	2007022435
Japan	6239169
South Korea	101665968
Israel	228952
Taiwan	I429428

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Keryx Biopharms